These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 25516647)
1. Hepatitis B and human immunodeficiency virus co-infection. Phung BC; Sogni P; Launay O World J Gastroenterol; 2014 Dec; 20(46):17360-7. PubMed ID: 25516647 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy. Gaglio PJ; Sterling R; Daniels E; Tedaldi E; Clin Infect Dis; 2007 Sep; 45(5):618-23. PubMed ID: 17682998 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review. Sun HY; Sheng WH; Tsai MS; Lee KY; Chang SY; Hung CC World J Gastroenterol; 2014 Oct; 20(40):14598-614. PubMed ID: 25356024 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B in HIV-infected patients. Soriano V; Poveda E; Vispo E; Barreiro P Clin Liver Dis; 2013 Aug; 17(3):489-501. PubMed ID: 23905818 [TBL] [Abstract][Full Text] [Related]
5. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients. Selabe SG; Lukhwareni A; Song E; Leeuw YG; Burnett RJ; Mphahlele MJ J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040 [TBL] [Abstract][Full Text] [Related]
6. Management and treatment of chronic hepatitis B in HIV-positive patients. Soriano V; de Mendoza C; Fernández-Montero JV; Labarga P; Barreiro P Ann Med; 2014 Aug; 46(5):290-6. PubMed ID: 24716736 [TBL] [Abstract][Full Text] [Related]
7. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy. Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus and HIV infection. Martín-Carbonero L; Poveda E Semin Liver Dis; 2012 May; 32(2):114-9. PubMed ID: 22760650 [TBL] [Abstract][Full Text] [Related]
9. The perils of relying on anti-hepatitis B total core antibody in screening individuals infected with HIV. Thng C; Babiker ZO; Brown B; Babu C Int J STD AIDS; 2012 Feb; 23(2):149-50. PubMed ID: 22422696 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of chronic hepatitis B in HIV co-infected patients]. Massard J; Benhamou Y Gastroenterol Clin Biol; 2008 Jan; 32(1 Pt 2):S20-4. PubMed ID: 18662606 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis B and human immunodeficiency virus coinfection. Thio CL Hepatology; 2009 May; 49(5 Suppl):S138-45. PubMed ID: 19399813 [TBL] [Abstract][Full Text] [Related]
12. Prevention of hepatocellular carcinoma in hepatitis B virus infection. Lim SG; Mohammed R; Yuen MF; Kao JH J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903 [TBL] [Abstract][Full Text] [Related]
13. Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients. Coffin CS; Osiowy C; Myers RP; Gill MJ J Clin Virol; 2013 Jun; 57(2):103-8. PubMed ID: 23465393 [TBL] [Abstract][Full Text] [Related]
14. Management of patients co-infected with hepatitis B virus and HIV. Núñez M; Soriano V Lancet Infect Dis; 2005 Jun; 5(6):374-82. PubMed ID: 15919623 [TBL] [Abstract][Full Text] [Related]
15. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G. Lada O; Gervais A; Branger M; Peytavin G; Roquebert B; Collin G; Fraqueiro G; Moucari R; Hamet G; Martinot-Peignoux M; Matheron S; Marcellin P Liver Int; 2012 Jan; 32(1):93-101. PubMed ID: 22097898 [TBL] [Abstract][Full Text] [Related]
17. Occult hepatitis B infection in patients infected with HIV: report of two cases of hepatitis B reactivation and prevalence in a hospital cohort. Bloquel B; Jeulin H; Burty C; Letranchant L; Rabaud C; Venard V J Med Virol; 2010 Feb; 82(2):206-12. PubMed ID: 20029819 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus. Dore GJ; Cooper DA; Pozniak AL; DeJesus E; Zhong L; Miller MD; Lu B; Cheng AK; ; J Infect Dis; 2004 Apr; 189(7):1185-92. PubMed ID: 15031786 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China. Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454 [TBL] [Abstract][Full Text] [Related]
20. Effect of HIV co-infection on mutation patterns of HBV in patients with lamivudine-resistant chronic hepatitis B. Iacomi F; Vincenti D; Vairo F; Solmone M; Mariano A; Piselli P; Puro V; Capobianchi MR; Antonucci G J Med Virol; 2009 Jul; 81(7):1151-6. PubMed ID: 19475624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]